Albany, NY -- (SBWire) -- 04/05/2019 --Cardiovascular diseases include a number of heart diseases such as congenital heart disease, coronary artery disease, and arrhythmias. Chest pain and heart attack can occur due to blockage in blood vessels. Symptoms of cardiovascular diseases are different in men and women; men are most likely to experience chest pain, while women may experience symptoms such as extreme fatigue, shortness of breath, and nausea. Cardiovascular reconstruction devices are used to remove the blockage in artery and veins. Cardiovascular grafts are used to replace the aorta in case of aortic aneurysm caused in blood vessels.

Read Report Details: https://www.transparencymarketresearch.com/cardiac-reconstruction-devices-market.html

Increase in incidence of cardiac surgeries due to the rise in prevalence of cardiac diseases is anticipated to drive the global cardiac reconstruction devices market. Rise in incidence of chronic cardiovascular diseases is also anticipated to propel the market across the globe. Furthermore, favorable reimbursement policies for cardiac patients is estimated to drive the global cardiac reconstruction devices market. According to the World Health Organization, cardiovascular disease is a one of the major causes of deaths across the world. Approximately 17.9 million deaths occurred in 2012 across the globe due to cardiovascular diseases. In April 2018, Terumo Aortic launched RelayPro Thoracic Stent Graft System for the treatment of thoracic endovascular aortic repair. In February 2018, Bentley Inno med GmbH launched BeGraft Plus stent graft in Europe for the treatment of acute perforations and aneurysms. In October 2018, LeMaitre Vascular acquired Cardial subsidiary of BD (Becton Dickinson & Company). The Cardial product line includes surgical glue, valvulotomes, and woven and knitted vascular grafts. This acquisition enabled the company to strengthen its product portfolio and expand the international footprint.

The global cardiac reconstruction devices market can be segmented based on product, application, end-user, and region. In terms of product, the market can be bifurcated into graft and patch. Growth of the graft segment can be ascribed to the increase in cardiovascular surgeries due to cardiac diseases. Based on application, the market can be divided into vascular repair, cardiac repair, and others. The cardiac repair segment has been expanding owing to the rise in prevalence of cardiac diseases.

Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=63132

Based on region, the global cardiac reconstruction devices market can be segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America constituted a significant share of the global market during the forecast period. Rise in prevalence of cardiac diseases owing to the aging population and presence of key players in the region are the factors anticipated to drive the market in the region. According to the American College of Cardiology Foundation, cardiovascular disease is the leading cause of death in the U.S. around 6.2 million people in U.S. suffered heart failure during 2013-2016. The cardiac reconstruction devices market in Europe is projected to expand, led by the increase in prevalence of cardiovascular diseases in the region. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period owing to the growth in prevalence of cardiac diseases due to the changing lifestyle and high unmet health care needs.

The global cardiac reconstruction devices market is highly fragmented due to the presence of a large number of market players. Large numbers of manufacturers hold prominent market share in their respective regions. Leading players engage in new product development to gain market share. A key trend of mergers and acquisitions and new product development among the leading players has been observed since the past few years. Prominent players operating in the global cardiac reconstruction devices market are W. L. Gore & Associates, Cardinal Health, LeMaitre Vascular, Terumo Cardiovascular Systems Corporation, Getinge AB, CryoLife, Inc., Baxter, MAQUET Holding B.V. & Co. KG, Edwards Lifesciences Corporation, and B. Braun Melsungen AG.

Opt for the Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=63132

About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.